Fostering Trust Between Parents of Children With Cancer and Physicians
Although most parents of children with cancer form trusting relationships with their children’s oncologists, poor outcomes may negatively affect this.
Practice Management Resource Center
Practice Management
Scientists Issue Call to Become “Antiracist” in Cancer Care and Research
Even with an “exponential growth” of URM students, “faculty diversity would remain static well into the next 50 years.”
The Twitter Effect on How Oncologists Conduct and Share Research
The social media platform can be useful as an education tool for oncologists to stay up to date on new research in oncology — but physicians still need to be mindful of the information sources.
ASCO Releases Position Statement on Home Infusion of Anticancer Treatments
ASCO raises concerns about the home infusion of anticancer therapies including patient and caregiver safety, adequate oncology infusion nurses, and reimbursement issues.
Restructured Process Overcomes Barriers to Prior Authorization for Proton Therapy
This study examined the impact of a restructured prior authorization process on the delivery of PBT at a proton therapy center.
Fertility Preservation Counseling Before Chemotherapy May Be Infrequent
Clinicians are more likely to counsel younger and female patients on reproductive risks before initiating chemotherapy, despite available ASCO guidelines.
Assessing Barriers and Facilitators of Timely Chemotherapy Delivery in the Ambulatory Care Setting
Researchers examined causes of avoidable chemotherapy delays as a means of improving the quality of care for outpatients receiving chemotherapy.
Can Advocacy Groups Provide Useful Patient-Centered Data?
A survey presented during ASCO20 found that patients who considered themselves adequately informed felt “in control” most days.
First Guidelines for Providing Oncology Pharmacy Services in COVID-19
The first set of guidelines for providing oncology pharmacy services to cancer patients during the COVID-19 pandemic was recently published.
A Majority of Anticancer Drug Approvals Are Based on Trials With Core Limitations, Say Researchers
Core limitations were defined as lack of randomization, lack of overall survival data, inappropriate use of crossover, and use of suboptimal control arms.
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Practice Management
